{
  "url": "https://openlegislation.uk/eu-regulation-2017-644/annex-III/division-8/division-3",
  "json_url": "https://openlegislation.uk/eu-regulation-2017-644/annex-III/division-8/division-3.json",
  "legislation": "eur/2017/644",
  "legislation_title": "Commission Regulation (EU) 2017/644 of 5 April 2017 laying down methods of sampling and analysis for the control of levels of dioxins, dioxin-like PCBs and non-dioxin-like PCBs in certain foodstuffs and repealing Regulation (EU) No 589/2014 (Text with EEA relevance)",
  "legislation_url": "https://openlegislation.uk/eu-regulation-2017-644",
  "path": "annex/III/division/8/division/3",
  "kind": "division",
  "number": null,
  "heading": "Physico-chemical screening methods",
  "text": "The result of the screening shall be expressed as compliant or suspected to be non-compliant (‘suspected’).\nFor each type of sample matrix, the report shall mention the maximum or action level on which the evaluation is based.\nIn addition, levels for individual PCDD/F and/or dioxin-like PCB congeners and TEQ-values reported as lower-bound, upper-bound and medium-bound may be given. The results shall be expressed in the same units and with (at least) the same number of significant figures as the maximum levels laid down in Regulation (EC) No 1881/2006.\nThe recoveries of the individual internal standards must be made available in case the recoveries are outside the range mentioned in point 6.2 and in other cases upon request.\nThe report shall mention the GC-MS method applied.\nThe report shall also include the method used for extraction of PCDD/Fs, dioxin-like PCBs and lipids. The lipid content of the sample shall be determined and reported for food matrices with maximum levels expressed on fat basis and with an expected fat concentration in the range of 0-2 % (in correspondence to existing legislation). For other samples, the determination of the lipid content is optional.\nIn case of samples suspected to be non-compliant, the report needs to include a note on the action to be taken. The concentration of PCDD/Fs and the sum of PCDD/Fs and dioxin-like PCBs in those samples with elevated levels has to be determined/confirmed by a confirmatory method.\nNon-compliance can only be decided after confirmatory analysis.",
  "extent": "E+W+S+N.I.",
  "status": null,
  "version": "current",
  "annotations": [],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/eur/2017/644/annex/III/division/8/division/3",
    "retrieved_at": "2026-11-01T14:45:03.439389+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}